Literature DB >> 7269554

The hemolytic-uremic syndrome.

C Brasher, R L Siegler.   

Abstract

Our experience with 61 episodes of the hemolytic-uremic syndrome in 60 patients showed a mean patient age of 3 years and a higher incidence of the disease during the summer months. Diarrhea, often bloody, preceded the other features of the illness in 93 percent of the cases. Hemolytic anemia, hematuria and proteinuria occurred in all of the patients. Thrombocytopenia and severe azotemia (blood urea nitrogen greater than 100 mg per dl) occurred in 74 percent and 72 percent of the children, respectively. Blood transfusions were necessary in 64 percent and dialysis was required in 54 percent of the cases. Mortality was low (5 percent) and 85 percent of the children had a complete recovery.

Entities:  

Mesh:

Year:  1981        PMID: 7269554      PMCID: PMC1272601     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  12 in total

1.  Renal microangiopathy of the hemolytic-uremic syndrome in childhood.

Authors:  M C Riella; C R George; R O Hickman; G E Striker; S J Slichter; L Harker; L J Quadracci
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Hyperuricemia in the hemolytic-uremic syndrome.

Authors:  B S Kaplan; P D Thomson
Journal:  Am J Dis Child       Date:  1976-08

Review 3.  Hemolytic-uremic syndrome.

Authors:  M H Goldstein; J Churg; L Strauss; D Gribetz
Journal:  Nephron       Date:  1979       Impact factor: 2.847

4.  Heparin therapy in the hemolytic-uremic syndrome.

Authors:  M Vitacco; J Sanchez Avalos; C A Gianantonio
Journal:  J Pediatr       Date:  1973-08       Impact factor: 4.406

5.  Hemolytic-uremic syndrome.

Authors:  E Lieberman
Journal:  J Pediatr       Date:  1972-01       Impact factor: 4.406

6.  An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome.

Authors:  B S Kaplan; J Katz; S Krawitz; A Lurie
Journal:  J Pediatr       Date:  1971-03       Impact factor: 4.406

Review 7.  The hemolytic uremic syndrome.

Authors:  B S Kaplan; P D Thomson; J P de Chadarévian
Journal:  Pediatr Clin North Am       Date:  1976-11       Impact factor: 3.278

8.  The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome.

Authors:  D Dolislager; B Tune
Journal:  Am J Dis Child       Date:  1978-01

9.  The importance of nonrenal involvement in hemolytic-uremic syndrome.

Authors:  K Upadhyaya; K Barwick; M Fishaut; M Kashgarian; N J Siegel
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

10.  CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.

Authors:  J F Bale; C Brasher; R L Siegler
Journal:  Am J Dis Child       Date:  1980-09
View more
  11 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

2.  Rasburicase for hyperuricemia in hemolytic uremic syndrome.

Authors:  Alisa A Acosta; Ronald J Hogg
Journal:  Pediatr Nephrol       Date:  2011-11-17       Impact factor: 3.714

3.  Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2014-08-21       Impact factor: 3.714

4.  Hemolytic-uremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland.

Authors:  J S Kinney; T P Gross; C C Porter; M F Rogers; L B Schonberger; E S Hurwitz
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

5.  In vitro prostacyclin production in the hemolytic-uremic syndrome.

Authors:  R L Siegler; J B Smith; M B Lynch; S F Mohammad
Journal:  West J Med       Date:  1986-02

6.  Distribution of Gb(3) Immunoreactivity in the Mouse Central Nervous System.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Toxins (Basel)       Date:  2010-08       Impact factor: 4.546

7.  Sub-Lethal Dose of Shiga Toxin 2 from Enterohemorrhagic Escherichia coli Affects Balance and Cerebellar Cytoarchitecture.

Authors:  Luciana D'Alessio; Alipio Pinto; Adriana Cangelosi; Patricia A Geoghegan; Carla Tironi-Farinati; Gabriela J Brener; Jorge Goldstein
Journal:  Front Microbiol       Date:  2016-02-10       Impact factor: 5.640

8.  Hemolytic-uremic syndrome in asir region.

Authors:  N N Al Harbi; M E Elawad; M A Al Homrany
Journal:  J Family Community Med       Date:  1996-01

9.  Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons.

Authors:  Fumiko Obata; Lauren M Hippler; Progyaparamita Saha; Dakshina M Jandhyala; Olga S Latinovic
Journal:  Front Mol Neurosci       Date:  2015-07-14       Impact factor: 5.639

10.  Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex.

Authors:  Alipio Pinto; Mariana Jacobsen; Patricia A Geoghegan; Adriana Cangelosi; María Laura Cejudo; Carla Tironi-Farinati; Jorge Goldstein
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.